Marisa Lúcia Romani Paraboni | Immunology and Microbiology | Editorial Board Member

Published on by World Top Scientists

Prof. Dr. Marisa Lúcia Romani Paraboni | Immunology and Microbiology | Editorial Board Member

Professor | Fundação Universidade Regional Integrada Campus Erechim | Brazil

Prof. Dr. Marisa Lúcia Romani Paraboni, a faculty member at the Universidade Federal de São Paulo, is an accomplished scholar recognized for her contributions to her field of expertise, where she integrates advanced research, academic leadership, and interdisciplinary collaboration. She holds graduate and postgraduate degrees in areas aligned with her specialization, complemented by advanced training that strengthened her methodological and analytic foundations. Throughout her career, she has served in academic and professional roles that include leading research initiatives, mentoring emerging scholars, and contributing to institutional and collaborative projects that advance scientific inquiry and public impact. Her research focuses on key thematic areas relevant to her discipline, and her scholarly output includes peer-reviewed publications, contributions to collective volumes, and dissemination activities that support knowledge translation and community engagement. She has been recognized with honors that reflect her academic excellence, service, and professional standing, and she contributes to the scholarly community through editorial activities, participation in academic societies, and involvement in committees that uphold research quality and ethical standards. Her commitment to advancing science, fostering innovation, and strengthening her field positions her as a distinguished candidate for this award.

Profiles:  Scopus

Featured Publications

1. Author(s). (2022). Comparative study of oxidative stress and antioxidative markers in patients infected with Toxoplasma gondii. Parasitology International, volume(issue), pages.

Her work advances scientific understanding and clinical insight by integrating rigorous research with practical applications that strengthen public health and diagnostic practices. Through her contributions to biomedical investigation and academic leadership, she supports innovation that enhances societal well-being and informs evidence-based decision-making.

Aneta Guzek | Bloodstream Infections | Best Researcher Award

Published on by World Top Scientists

Dr. Aneta Guzek | Bloodstream Infections | Best Researcher Award

Head of Microbial Laboratory | National Research Institute | Poland

Dr. Aneta Guzek is the Head of the Microbiology Laboratory at the Military Institute of Medicine – National Research Institute in Warsaw, Poland, specializing in medical microbiology and laboratory diagnostics. She holds a PhD in medicine with a specialization in medical microbiology from the Military Institute of Medicine, complemented by postgraduate qualifications in medical microbiology from the Medical University of Lublin and innovation management in the health care sector from Kozminski University. Additionally, she earned an MSc in biology with a focus on microbiology from the University of Warsaw and is a certified laboratory diagnostician. Dr. Guzek leads a multidisciplinary team overseeing comprehensive microbiological diagnostics, implementation of advanced diagnostic methods, and the development of institutional policies on infection control and antibiotic stewardship. Her research contributions include studies on antimicrobial resistance, hospital infection control, and the advancement of microbiological procedures, with numerous publications and citations in recognized scientific sources. She collaborates with national and reference laboratories, contributing to public health and medical innovation. Her exemplary service has been recognized with prestigious honors, including the first place in the Hippocrates Medical Poll for Laboratory Diagnostician of the Year and the Badge of Honour from the Military Medical Institute for her efforts during the COVID-19 pandemic. Dr. Guzek also holds certification in Good Clinical Practice (ICH E6 R2), underscoring her commitment to excellence in research and clinical integrity.

Profiles: Scopus | ORCID

Featured Publications

1. Guzek, A., et al. (2025). Microbiological comparison of maxillary sinus rinses in non-odontogenic and odontogenic sinusitis of primarily endodontic origin. Journal of Clinical Medicine.

2. Guzek, A., et al. (2024). Outcomes of 23 patients diagnosed with New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae infection treated with ceftazidime/avibactam and aztreonam at a single center in Poland. Journal of Clinical Medicine.

3. Guzek, A., et al. (2024). Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023. Eurosurveillance.

HIkmate Abriouel | Microbiology | Best Researcher Award 

Published on by World Top Scientists

Prof. HIkmate Abriouel | Microbiology | Best Researcher Award 

 Professor at University of Jaén ,Spain

Dr. Hikmate Abriouel is a distinguished Full Professor of Microbiology at the University of Jaén, Spain. With a PhD in Biological Sciences, she is a globally recognized researcher, featured in Stanford’s Top 2% Scientists list (2021–2024). Her academic career is marked by leadership in microbiological research and education. She leads the “Microbiology and Health” group, focusing on antimicrobial resistance and probiotics of vegetable origin. Currently serving as Vice-Rector of Official Education at the University of Jaén, she has contributed significantly to curriculum reform, including the implementation of the Medicine degree. Dr. Abriouel is deeply involved in international research collaborations, has mentored numerous PhD scholars, and is known for her strong commitment to science communication and outreach. Her scholarly work includes over 160 indexed articles and several editorial roles. She remains an influential figure in advancing microbiology through an inclusive, multidisciplinary, and globally connected research approach.

🔹Professional Profile 

🏆Strengths for the Award

  1. Outstanding Academic Record

    • PhD in Biological Sciences, extensive postdoctoral international training.

    • Over 160 indexed publications, with a Scopus h-index of 51 and 9400+ citations, reflecting sustained and influential scholarly output.

  2. Global Recognition

    • Consistently featured in Stanford’s Top 2% Scientists (2021–2024).

    • Recognized as a Highly Cited Researcher, indicating international impact.

  3. Research Leadership and Innovation

    • Leads the “Microbiology and Health” research group with a focus on AMR, probiotics, and One Health approaches.

    • 27 funded national and international research projects, many with cross-disciplinary and applied relevance.

    • Holds patents, showcasing translation of science into practical applications.

  4. Educational Contributions

    • Vice-Rector of Official Education at the University of Jaén.

    • Played a key role in launching the Medicine degree, driving academic reform.

    • Mentored over 12 PhD scholars, promoting the next generation of microbiologists.

  5. Knowledge Transfer & Industry Collaboration

    • Involved in 12 industry-partnered research contracts, bridging academia and the private sector.

    • Research has direct relevance to public health, food safety, agriculture, and biotechnology.

  6. Editorial and Community Engagement

    • Guest editor for top journals (e.g., Microorganisms, IJMS).

    • Active in science communication and promoting inclusive, multidisciplinary collaboration.

Education 

Dr. Hikmate Abriouel earned her PhD in Biological Sciences, laying a strong foundation for her career in microbiology. Her academic journey reflects a deep commitment to interdisciplinary and impactful scientific work. Her training involved in-depth exposure to microbiological sciences, biotechnology, and public health, particularly in food microbiology and antimicrobial resistance. Throughout her studies, Dr. Abriouel pursued advanced methodologies and scientific inquiry that would later define her contributions to the field. She enhanced her academic profile through research stays in Germany and France, gaining international perspectives on microbiological and public health challenges. These experiences enriched her approach to research, particularly in integrating laboratory-based microbiology with real-world applications. She continues to contribute to higher education as a professor and university leader, advocating for innovative learning models and curriculum reforms. Her educational background, bolstered by continuous learning and global academic exposure, plays a vital role in shaping her as a leader in microbiology and public health.

Professional Experience 

Dr. Hikmate Abriouel has over two decades of academic and research experience in microbiology. As a Full Professor at the University of Jaén, she leads the “Microbiology and Health” research group, specializing in antimicrobial resistance, probiotics, and One Health strategies. Her research spans 27 national and international projects, and she has collaborated with leading scientists across Europe. She also serves as Vice-Rector of Official Education, where she has played a transformative role in modernizing educational programs, notably initiating the university’s Medicine degree. Her experience includes consultancy through 12 industry-partnered research contracts under the university’s Knowledge Transfer Plan. In addition to her research and administrative duties, Dr. Abriouel has mentored more than 12 doctoral students and serves as guest editor for international scientific journals. Her work bridges academic research, industrial applications, and educational leadership, making her a prominent figure in shaping microbiological sciences at both institutional and international levels.

Awards and Honors

Dr. Hikmate Abriouel’s contributions have earned her numerous recognitions. She is featured among the world’s Highly Cited Researchers and listed in Stanford’s prestigious Top 2% Scientists (2021–2024). In acknowledgment of her scientific stature, she is a Permanent Member of the Royal Academy of Veterinary Sciences of Eastern Andalusia. Her scholarly excellence is reflected in her impressive citation record, with an h-index of 51 and over 9400 citations in Scopus, positioning her among the most influential microbiologists globally. She has also served as a guest editor for renowned journals such as International Journal of Molecular Sciences and Microorganisms, further validating her academic influence. She has received competitive research grants and recognition for industry-related knowledge transfer through her work with private-sector collaborations. Her leadership in university governance and public health research continues to attract accolades, positioning her as a key opinion leader in microbiology, public health, and higher education innovation.

Research Focus on Microbiology

Dr. Hikmate Abriouel’s research centers on critical areas of microbiology with global health implications. Her primary focus lies in antimicrobial resistance (AMR), where she explores resistance mechanisms at the phenotypic and genotypic levels, especially in the food chain. She integrates this research within the broader “One Health” framework, promoting a holistic approach to human, animal, and environmental health. She also pioneers studies in vegetable-origin probiotics, particularly from fermented olives, exploring their potential in promoting gut health. Another significant area of her work addresses the antimicrobial activity of substances against plant pathogens such as Xylella fastidiosa and Verticillium dahliae. She has published a patented surface disinfectant and has two more patents under process. Her contributions align with UN Sustainable Development Goals, notably Goal 2 (Zero Hunger) and Goal 12 (Responsible Consumption). Her research not only deepens scientific understanding but also contributes practical solutions for food safety, agriculture, and public health.

📚 Publications Top Notes

Co-cultures of lactic acid bacteria from Brazilian foods as inhibitors of Listeria monocytogenes and Escherichia coli O157:H7 biofilm formation

Authors: [Names not provided]
Journal: Heliyon (2025)
Summary:
This study investigates how combinations of lactic acid bacteria (LAB) isolated from traditional Brazilian foods can inhibit biofilm formation of dangerous pathogens like Listeria monocytogenes and E. coli O157:H7. The results suggest a natural, food-origin microbial solution for controlling biofilms in food safety.

Antimicrobial activity of environmental Bacillus spp. and Peribacillus spp. isolates linked to surfactin, fengycin, bacillibactin and lantibiotics

Authors: [Names not provided]
Journal: International Journal of Biological Macromolecules (2025)
Summary:
This paper examines the antimicrobial potential of environmental strains of Bacillus and Peribacillus, focusing on secondary metabolites like surfactin, fengycin, and lantibiotics. These compounds demonstrate promising bioactivity against pathogens, highlighting their value in biotechnology and natural antimicrobial development.

Transcriptomic analysis of sub-MIC Eugenol exposition on antibiotic resistance profile in Multidrug Resistant Enterococcus faecalis E9.8

Authors: [Names not provided]
Journal: Microbiological Research (2025)
Summary:
This study analyzes how exposing MDR Enterococcus faecalis to sub-inhibitory concentrations of eugenol affects its gene expression, especially related to antibiotic resistance. The transcriptomic data provide insights into the adaptive mechanisms of bacterial resistance and the potential of natural compounds like eugenol in controlling it.

A microalgae Picochlorum sp. AZL19 from Moroccan Mediterranean as a novel source of antioxidant compounds

Authors: [Names not provided]
Journal: Algal Research (2025)
Summary:
The research explores a newly isolated strain of Picochlorum microalgae from the Moroccan Mediterranean coast, emphasizing its production of antioxidant compounds. Findings support its potential in nutraceutical and cosmetic applications due to its bioactive properties.

Impact of disinfection methods used in the slaughterhouse environment on microbiome diversity throughout the meat production chain

Authors: [Names not provided]
Journal: Current Research in Microbial Sciences (2025)
Summary:
This article evaluates how various disinfection techniques in slaughterhouses influence the microbial diversity along the meat supply chain. The research underlines the need for microbiome-conscious disinfection strategies that balance hygiene with microbial ecosystem preservation.

Phenotypic and Genomic Insights Into Bacillus spp. and Peribacillus spp. of Spanish Olive Groves With Biotechnological Potential

Authors: [Names not provided]
Journal: Environmental Microbiology Reports (2024)
Summary:
The study combines phenotypic and genomic approaches to characterize Bacillus and Peribacillus species from olive grove soils in Spain. It highlights their potential in agricultural biotechnology, especially in biocontrol and plant growth promotion.

Exploring synergistic effects of essential oil compounds with antibiotics and biocides against multidrug-resistant foodborne pathogens

Authors: [Names not provided]
Journal: Applied Food Research (2024)
Summary:
This research investigates how combining essential oil components with traditional antibiotics and biocides can enhance antimicrobial efficacy against MDR foodborne pathogens. It supports the potential for integrated natural-synthetic antimicrobial strategies in food safety.

Corrigendum to “Virulence factors, antibiotic resistance, and bacteriocins in enterococci from artisan foods of animal origin”

Authors: [Names not provided]
Original Journal: Food Control (2009)
Summary:
This corrigendum addresses errors in the previously published article about enterococci strains from artisanal foods, focusing on virulence, resistance, and bacteriocin profiles. It ensures accuracy and clarity in the historical scientific record.

Dual effects of a bacteriocin-producing Lactiplantibacillus pentosus CF-6HA, isolated from fermented aloreña table olives, as potential probiotic and antimicrobial agent

Authors: [Names not provided]
Journal: Heliyon (2024)
Summary:
The article presents a strain of L. pentosus from olives with dual functionality—offering probiotic benefits and antimicrobial properties via bacteriocin production. It could serve both as a dietary supplement and a natural preservative.

Antimicrobial profile of the culturable olive sporobiota and its potential as a source of biocontrol agents for major phytopathogens in olive agriculture

Authors: [Names not provided]
Journal: Pest Management Science (2024)
Summary:
This study characterizes spore-forming microbes from olives and examines their antimicrobial activity against key phytopathogens. The results suggest that olive-associated sporobiota can be tapped for sustainable biocontrol in olive cultivation.

Conclusion 

Dr. Hikmate Abriouel exemplifies the blend of academic excellence, impactful research, and leadership in higher education. Her career spans advanced research in microbiology, dedication to combating global health threats like antimicrobial resistance, and a strong focus on food safety and sustainability. As a mentor and educator, she has shaped the careers of future scientists while playing a strategic role in enhancing medical education at the University of Jaén. Her interdisciplinary collaborations, both within Spain and internationally, reflect her ability to foster innovation through partnership. Recognition as a Highly Cited Researcher and her position in Stanford’s Top 2% Scientists underline the global impact of her work. Through her patented innovations, extensive publications, and academic governance, she continues to contribute meaningfully to both science and society. Dr. Abriouel’s career reflects a lifelong commitment to advancing microbiological science while supporting education, innovation, and inclusive scientific communication across local and global communities.

 

Mohamed-Zakaria Assani | Immunology and Microbiology | Best Researcher Award

Published on by World Top Scientists

Dr. Mohamed-Zakaria Assani | Immunology and Microbiology | Best Researcher Award

PhD Student at University of Medicine and Pharmacy of Craiova, Romania

Mohamed-Zakaria Assani is a dedicated and academically accomplished medical professional from Craiova, Romania. A graduate of the University of Medicine and Pharmacy of Craiova with a Doctor of Medicine degree, he is currently pursuing a PhD in Immunology, focusing on the implications of inflammation and atherosclerosis in chronic kidney disease. His academic excellence is reflected in his high GPAs and his master’s dissertation on population exposure to ionizing radiation. Mohamed-Zakaria has demonstrated leadership and community engagement through roles such as Project Coordinator for ONCOHELP and active volunteer work within student medical societies. He has participated in numerous congresses and clinical workshops, enhancing his practical and theoretical knowledge. Proficient in English and skilled in digital tools, he is well-equipped for research communication and collaboration. With a strong foundation in clinical research and a growing academic profile, he stands out as a promising early-career researcher committed to advancing medical science.

Professional Profile

ORCID Profile

Education

Mohamed-Zakaria Assani has an impressive academic background rooted in medical sciences. He graduated with a Doctor of Medicine (MD) degree from the University of Medicine and Pharmacy of Craiova, achieving an outstanding overall GPA of 9.69 and a dissertation exam GPA of 9.92. His academic excellence dates back to high school, where he earned a Baccalaureate GPA of 9.50 from the National College Frații Buzești in Craiova. Currently, he is pursuing a PhD in Immunology at the same university, where his research explores the interplay between inflammation, atherosclerosis, and chronic kidney disease—an area of critical importance in modern healthcare. His educational journey demonstrates consistent high performance, intellectual curiosity, and a solid foundation in both theoretical and practical aspects of medicine. He has also earned English language certifications (C1 level), further supporting his ability to engage with international research communities and access global academic resources effectively.

Professional Experience

Mohamed-Zakaria Assani has gained practical medical and leadership experience through a series of impactful roles. Currently, he serves as a resident in Laboratory Medicine at Filantropia Clinical Hospital and the Clinical Hospital of Neuropsychiatry in Craiova. These roles have enabled him to develop core diagnostic and analytical skills essential for laboratory-based and clinical research. Earlier in his academic journey, he demonstrated initiative and community engagement as a project coordinator for ONCOHELP within SSM Craiova and as a volunteer for various student-led projects, including TRANSMED and university-wide events such as the Freshman Ball. His participation in medical workshops and congresses—like the Annual Congress of Surgery for Students and CIMSC—further underscores his dedication to continuous professional development. These experiences have not only broadened his clinical perspective but also allowed him to build strong interpersonal and organizational skills, both crucial for team-based medical research and healthcare practice.

Research Interest

Mohamed-Zakaria Assani’s research interests lie at the intersection of immunology, cardiovascular pathology, and nephrology, focusing specifically on how inflammation and atherosclerosis contribute to chronic kidney disease (CKD). This multidisciplinary approach highlights his commitment to understanding complex disease mechanisms and improving patient outcomes through evidence-based research. His PhD work delves into the cellular and molecular pathways that drive disease progression in CKD, a pressing global health challenge. Additionally, his master’s dissertation explored population exposure to ionizing radiation from high-performance radiological investigations, demonstrating his early concern for public health and medical safety. Mohamed-Zakaria is driven by a desire to bridge laboratory findings with clinical applications, and his work holds the potential to inform diagnostic tools, therapeutic strategies, and preventive measures. His research aims not only to contribute new knowledge to the scientific community but also to enhance clinical practice, particularly in the management of chronic and systemic diseases.

Award and Honor

Although specific formal awards are not listed, Mohamed-Zakaria Assani’s academic record and extracurricular achievements position him as a strong candidate for recognition in research and leadership. Graduating with distinction from both high school and medical school, and earning high scores on his dissertation, he has consistently demonstrated academic excellence. His selection as a Project Coordinator within SSM Craiova for the ONCOHELP initiative, along with his active participation in prestigious student congresses such as CIMSC and the Annual Congress of Surgery, reflects peer and institutional acknowledgment of his capabilities. He also holds English proficiency certifications (Cambridge C1), further validating his readiness for international academic participation. His combination of scholarly commitment, volunteer service, and leadership roles speaks to a well-rounded and motivated individual deserving of early-career honors, such as young researcher awards or medical innovation fellowships. His profile illustrates promise and preparedness for future accolades in the field of medical research.

Conclusion

In conclusion, Mohamed-Zakaria Assani is a highly motivated and capable early-career medical researcher with a commendable blend of academic achievement, clinical experience, and leadership involvement. His educational accomplishments and current doctoral work in immunology place him at the forefront of critical research on chronic kidney disease. He has proactively contributed to both academic and volunteer communities, showing a strong sense of responsibility and dedication to healthcare. While he would benefit from expanding his research portfolio through publications and international collaborations, his foundational strengths are undeniable. With a clear focus on impactful, multidisciplinary research and a history of academic excellence, he is exceptionally well-positioned to contribute to the future of medical science. He is a promising candidate for research awards and a strong example of emerging talent in laboratory and clinical medicine. His continued progress will no doubt lead to significant contributions in the medical and scientific fields.

Publications Top Notes

1. Association Between Pentraxins and Obesity in Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus Patients

  • Authors: Roxana-Viorela Ahrițculesei, Lidia Boldeanu, Daniel Cosmin Caragea, Mihaela Vladu, Diana Clenciu, Adina Mitrea, Anca Marilena Ungureanu, Constantin Cristian Văduva, Anda Lorena Dijmărescu, Alin Iulian Silviu Popescu, et al.

  • Year: 2025

  • Citation: Ahrițculesei, R.-V., Boldeanu, L., Caragea, D. C., Vladu, M., Clenciu, D., Mitrea, A., Ungureanu, A. M., Văduva, C. C., Dijmărescu, A. L., Popescu, A. I. S., et al. (2025). Association Between Pentraxins and Obesity in Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus Patients. International Journal of Molecular Sciences, 26(8), 3661. https://doi.org/10.3390/ijms26083661

2. Potential Association Between Atherogenic Coefficient, Prognostic Nutritional Index, and Various Obesity Indices in Diabetic Nephropathy

  • Authors: Mohamed-Zakaria Assani, Marius Bogdan Novac, Anda Lorena Dijmărescu, Constantin Cristian Văduva, Mihaela Vladu, Diana Clenciu, Adina Mitrea, Roxana-Viorela Ahrițculesei, Alexandra-Ștefania Stroe-Ionescu, Alexandru-Dan Assani, et al.

  • Year: 2025

  • Citation: Assani, M.-Z., Novac, M. B., Dijmărescu, A. L., Văduva, C. C., Vladu, M., Clenciu, D., Mitrea, A., Ahrițculesei, R.-V., Stroe-Ionescu, A.-Ș., Assani, A.-D., et al. (2025). Potential Association Between Atherogenic Coefficient, Prognostic Nutritional Index, and Various Obesity Indices in Diabetic Nephropathy. Nutrients, 17(8), 1339. https://doi.org/10.3390/nu17081339

3. Radiation Exposure of Patients Undergoing Multiple-Slice CT Scans in Romania

  • Authors: I. Prejbeanu, M. Z. Assani, F. Niculescu, L. A. Prunariu, R. G. Prejbeanu

  • Year: 2024

  • Citation: Prejbeanu, I., Assani, M. Z., Niculescu, F., Prunariu, L. A., & Prejbeanu, R. G. (2024). Radiation Exposure of Patients Undergoing Multiple-Slice CT Scans in Romania. European Journal of Public Health, 34(Supplement 1), ckae144.2140. https://doi.org/10.1093/eurpub/ckae144.2140

Tuba Yuce Inel | Immunology and Microbiology | Best Researcher Award

Published on by World Top Scientists

Dr. Tuba Yuce Inel | Immunology and Microbiology | Best Researcher Award

MD at Izmir City Hospital, Turkey

Dr. Tuba Yüce İnel is a dedicated physician and researcher specializing in internal medicine, immunology, and rheumatology. With extensive experience in clinical practice and academic research, she has contributed significantly to the study of autoimmune diseases, inflammatory conditions, and rheumatological disorders. Her research focuses on understanding disease mechanisms and improving treatment approaches for complex conditions such as systemic sclerosis, ankylosing spondylitis, and rheumatoid arthritis. Dr. İnel has published multiple papers in high-impact international journals, providing valuable insights into disease management and patient outcomes. Actively involved in scientific collaborations, she has participated in various national research projects aimed at advancing rheumatological medicine. She has also been recognized for her contributions with prestigious awards, highlighting her expertise and commitment to medical science.

Professional Profile

Education

Dr. Tuba Yüce İnel began her medical education at Hacettepe University School of Medicine, where she earned her Bachelor’s degree in Medicine in 2012. She then pursued a specialization in internal medicine at Istanbul University Faculty of Medicine, completing her training in 2017 with a thesis on the side effects of immunosuppressive treatments in primary glomerular diseases. Her academic journey continued with a minor specialization in Immunology and Rheumatology at Dokuz Eylül University, where she completed her training in 2022. Through her education at leading Turkish medical institutions, Dr. İnel gained extensive clinical expertise and research experience, shaping her career in autoimmune and inflammatory diseases.

Professional Experience

Dr. İnel has held key positions as a Research Assistant at both Istanbul University (2012-2017) and Dokuz Eylül University (2018-present), where she has contributed to research and medical education. She has played a significant role in clinical studies related to autoimmune diseases, particularly focusing on systemic sclerosis and inflammatory pathways. Additionally, she has been actively involved in teaching and mentoring medical students and residents, sharing her expertise in rheumatology and immunology. Her professional journey includes participation in several government-funded scientific research projects, further solidifying her role as a leading researcher in rheumatology.

Research Interests

Dr. İnel’s research focuses on autoimmune diseases, inflammatory rheumatologic disorders, and immunology, with a particular emphasis on systemic sclerosis, ankylosing spondylitis, and rheumatoid arthritis. She has explored the role of immune pathways, including the NEK7-NLRP3 inflammasome pathway, in disease progression and treatment response. Her studies on plasma arginine-citrulline levels in systemic sclerosis have contributed to understanding disease severity and malabsorption mechanisms. Additionally, her research on obesity’s impact on ankylosing spondylitis treatment has provided real-world data on therapeutic outcomes. She continues to investigate novel biomarkers and targeted treatments to improve patient care and enhance therapeutic strategies in rheumatology.

Awards and Honors

Dr. İnel’s outstanding research has earned her recognition and accolades within the medical community. In 2022, she won the First Prize for Oral Presentation in Spondyloarthritis, awarded by the Turkish Rheumatology Association, highlighting her excellence in presenting groundbreaking research. Her work has been published in internationally recognized journals, showcasing her significant contributions to rheumatology and immunology. She is also an active member of the Turkish Rheumatology Association, reflecting her commitment to advancing knowledge and collaboration in her field. Through her academic achievements, research excellence, and clinical expertise, Dr. İnel continues to establish herself as a leading figure in rheumatology research.

Conclusion

Dr. Tuba Yüce İnel is a strong candidate for the Best Researcher Award due to her academic achievements, impactful research in rheumatology, national recognition, and continuous contributions to scientific literature. If she enhances international collaborations, takes leadership roles in research projects, and secures external funding, her candidacy would become even more compelling.

Publications Top Noted

1. A Life-Threatening Manifestation of Granulomatosis with Polyangiitis: Subglottic Stenosis

  • Authors: Yüce-İnel, T., Uslu, S.
  • Year: 2024
  • Journal: Archives of Rheumatology
  • Citations: 0

2. Assessing Safety and Efficacy of TNFi Treatment in Late-Onset Ankylosing Spondylitis: A TURKBIO Registry Study

  • Authors: Uslu, S., Gülle, S., Sen, G., Akkoç, N., Onen, F., Yüce-İnel, T.
  • Year: 2024
  • Journal: Scientific Reports
  • Citations: 4

 

TOSHIFUMI OHKUSA | Microbiology | Best Researcher Award

Published on by World Top Scientists

Prof. TOSHIFUMI OHKUSA | Microbiology | Best Researcher Award

Special Professor, juntendo, Japan

Dr. Toshifumi Ohkusa is a highly regarded expert in gastroenterology and microbiota research, with a distinguished career spanning over four decades. He is currently a Special Professor at the Department of Microbiota Research at Juntendo University Graduate School of Medicine. Dr. Ohkusa has made significant contributions to the field of gastroenterology, particularly in understanding ulcerative colitis and intestinal microflora. 🌟👨‍⚕️

Publication profile

Scopus

 

Education

Dr. Ohkusa completed his medical degree (M.D.) from Tokyo Medical and Dental University in 1978. He pursued a Ph.D. from the same institution, where his groundbreaking research on ulcerative colitis in hamsters through dextran sulfate sodium and changes in intestinal microflora earned him a doctorate in 1986. 🎓📚

Experience

With an impressive academic journey, Dr. Ohkusa served as a Research Associate and Instructor at Tokyo Medical and Dental University from 1986 to 2001. He later joined Juntendo University, where he advanced from Assistant Professor to Associate Professor in the Department of Gastroenterology. Between 2008 and 2017, he held the prestigious position of Professor at The Jikei University Kashiwa Hospital. Currently, he leads microbiota research at Juntendo University. 💼🔬

Research Focus

Dr. Ohkusa’s research focuses on gastroenterology, particularly the mechanisms of ulcerative colitis and the role of intestinal microflora in gastrointestinal diseases. His work on microbiota research has significantly advanced the understanding of gastrointestinal health. 🔬🧫

Awards and Honors

Dr. Ohkusa has received numerous accolades for his groundbreaking work in gastroenterology and internal medicine, earning recognition from both Japanese and international medical societies. 🏆🌍

Publication Top Notes

Effect of probiotic bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: Results of a 24-week randomized, double-blind, placebo-controlled trial

Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease

Correction: The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis (BMC Gastroenterology, (2022), 22, 1, (390), 10.1186/s12876-022-02474-9)